| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/08/1995 | WO1995015339A1 Antagonists to chaperonin 10 |
| 06/08/1995 | WO1995015338A1 Chaperonin 10 |
| 06/08/1995 | WO1995015179A1 Method of treating intestinal disorders |
| 06/08/1995 | WO1995015172A1 Extract from the leaves of gingko biloba |
| 06/08/1995 | WO1995015166A1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 06/08/1995 | WO1995015155A1 Taste masked composition containing a drug/polymer complex |
| 06/08/1995 | WO1995015148A1 Topical preparations containing l-arginine |
| 06/08/1995 | DE4407484A1 Cancer medicament for parenteral admin. |
| 06/08/1995 | CA2177848A1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 06/08/1995 | CA2177721A1 Taste masked composition containing a drug/polymer complex |
| 06/08/1995 | CA2177584A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | CA2177570A1 Method of treating intestinal disorders |
| 06/08/1995 | CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer |
| 06/07/1995 | EP0656213A1 Treatment of conditions and disease |
| 06/07/1995 | EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 06/07/1995 | EP0656007A1 Opioid receptor genes |
| 06/07/1995 | EP0655914A1 Novel compositions |
| 06/07/1995 | EP0655912A1 Medicaments for the treatment or prevention of elevated intraocular pressure |
| 06/07/1995 | EP0616532A4 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease. |
| 06/07/1995 | EP0603312A4 Novel gaba a? receptor with steroid binding sites. |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/07/1995 | CN1103315A Improved methods for the determination and adjustment of prolactin daily rhythms |
| 06/06/1995 | US5422371 Contacting a cell with a fatty acid or fatty alcohol to prevent reduction of testosterone to 5a-dihydrotestosterone |
| 06/06/1995 | US5422370 Method of using 2-hydroxypropanoic acid (lactic acid) for the treatment of wrinkles |
| 06/06/1995 | US5422366 Forming oxygen-scavenging metal chelate or metal complex-containing film over nail to deprive aerobic fungi of oxygen |
| 06/06/1995 | US5422100 Method and product for treating skin afflictions |
| 06/06/1995 | US5422097 Combined antiviral and antimediator treatment of common colds |
| 06/01/1995 | WO1995014682A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 06/01/1995 | WO1995014493A1 Three-step pretargeting methods and compounds |
| 06/01/1995 | WO1995014483A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex |
| 06/01/1995 | WO1995014478A1 Purine compositions and methods for administration |
| 06/01/1995 | WO1995014473A1 Antiarrhythmic benzodiazepines |
| 06/01/1995 | WO1995014470A1 Methods of treating cardiac arrhythmia |
| 06/01/1995 | WO1995014468A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 06/01/1995 | WO1995014460A1 Opioid formulations for treating pain |
| 06/01/1995 | WO1995014436A1 A retrograde high frequency tissue splitter |
| 06/01/1995 | CA2177037A1 Three-step pretargeting methods and compounds |
| 06/01/1995 | CA2176251A1 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 06/01/1995 | CA2176021A1 Methods of treating cardiac arrhythmia |
| 06/01/1995 | CA2176016A1 Antiarrhythmic benzodiazepines |
| 06/01/1995 | CA2175828A1 Purine compositions and methods for administration |
| 06/01/1995 | CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 05/31/1995 | EP0655460A1 Pharmacotherapeutical use of glutathione derivatives |
| 05/31/1995 | EP0655249A1 Moenomycin as a medicament for the treatment of stomach ulcer |
| 05/31/1995 | EP0655235A1 Slimming composition |
| 05/31/1995 | EP0654999A1 Use of inhibitors of vacuolar-type h?+ atpases |
| 05/31/1995 | EP0654973A1 System of drug delivery to the lymphatic tissues |
| 05/31/1995 | CA2136936A1 Moenomycin and its derivatives for the production of pharmaceuticals, and pharmaceuticals containing moenomycin or its derivatives |
| 05/30/1995 | US5420152 Melatonin |
| 05/30/1995 | US5420106 Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
| 05/30/1995 | CA2050303C Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
| 05/26/1995 | WO1995014028A2 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 05/26/1995 | WO1995013827A1 A method for preventing or controlling cataract |
| 05/26/1995 | WO1995013821A1 αvβ3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS |
| 05/26/1995 | WO1995013820A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier |
| 05/26/1995 | WO1995013818A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
| 05/26/1995 | WO1995013813A1 Aminoanthraquinone derivatives to combat multidrug resistance |
| 05/26/1995 | WO1995013805A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases |
| 05/26/1995 | WO1995013803A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 05/26/1995 | WO1995013802A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor |
| 05/26/1995 | CA2176808A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 05/26/1995 | CA2176747A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases |
| 05/26/1995 | CA2176721A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor |
| 05/26/1995 | CA2176220A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor |
| 05/26/1995 | CA2176143A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 05/24/1995 | EP0654038A1 Controlled release pharmaceutical formulations of 3'-azido-3'-deoxythymidine and methods of use |
| 05/23/1995 | US5417968 Antimicrobial barrier composition |
| 05/19/1995 | CA2103399A1 Material for passage through the blood-brain barrier |
| 05/18/1995 | WO1995013294A1 Cytokines from natural killer or t cells |
| 05/18/1995 | WO1995013087A1 Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion |
| 05/18/1995 | WO1995013082A1 Immunotherapy composition and method |
| 05/18/1995 | WO1995013079A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide |
| 05/18/1995 | WO1995013072A1 The use of alfuzosin or terazosin in the treatment of premature ejaculation |
| 05/18/1995 | WO1995013062A1 Butyric ester cyto-differentiating agents |
| 05/18/1995 | CA2176386A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide |
| 05/18/1995 | CA2176114A1 Cytokines from natural killer or t cells |
| 05/18/1995 | CA2175564A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 05/18/1995 | CA2175249A1 Butyric ester cyto-differentiating agents |
| 05/17/1995 | EP0652776A1 Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them |
| 05/17/1995 | EP0652768A1 Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-alpha and histamine, serotonin or substances with corresponding receptor activity |
| 05/17/1995 | EP0652749A1 METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY |
| 05/16/1995 | US5416091 Agents for potentiating the effects of antitumor agents and combating multiple drug resistance |
| 05/16/1995 | CA1335572C Derivatives of cyclic amp as treatment for cancer |
| 05/11/1995 | WO1995012678A2 Improvements relating to cancer therapy |
| 05/11/1995 | WO1995012396A1 Method for inhibiting intracellular viral replication |
| 05/11/1995 | WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 05/11/1995 | WO1995012308A1 Method of introducing material into eggs during early embryonic development |
| 05/11/1995 | WO1995012307A1 Method and apparatus for early embryonic in ovo injection |
| 05/11/1995 | CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 05/11/1995 | CA2175186A1 Method of introducing material into eggs during early embryonic development |
| 05/11/1995 | CA2175181A1 Method and apparatus for early embryonic in ovo injection |
| 05/11/1995 | CA2153146A1 Method for inhibiting intracellular viral replication |
| 05/10/1995 | EP0652012A1 Combination of sugars with animo acids and other drugs |
| 05/10/1995 | EP0651816A1 Blood levels of cck peptides relative to panic disorder treatment |
| 05/10/1995 | EP0651740A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
| 05/10/1995 | EP0651636A1 Chemotherapy for cancer |
| 05/09/1995 | US5414014 Methods for efficacious removal of attached, sucking antropods from human dermis |
| 05/09/1995 | US5414011 Preservative system for ophthalmic formulations |
| 05/09/1995 | US5413999 HIV protease inhibitors useful for the treatment of AIDS |
| 05/09/1995 | US5413996 Targeted drug delivery via phosphonate derivatives |